Thync Overview

  • Founded
  • 2011
  • Status
  • Private
  • Employees
  • 25
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $6M
Latest Deal Amount
  • Investors
  • 6

Thync General Information


Developer of bioelectronic products designed to offer treatments for autoimmune disorders and mental health. The company's products target autonomic pathways important in a number of disease processes while providing safety and focus on commercialization of neurostimulation patches for consumer applications, enabling users to boost their energy level by directly activating nerves and neurons.

Contact Information

Formerly Known As
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Primary Office
  • 140 West Main Street
  • Los Gatos, CA 95030
  • United States
+1 (408) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Thync Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) 16-Feb-2018 $6M 000.00 Completed Generating Revenue
6. Equity Crowdfunding 000.00 Completed Startup
5. Early Stage VC (Series B2) 23-Jan-2015 000.00 000.00 000.00 Completed Startup
4. Early Stage VC (Series B1) 08-Oct-2014 00.00 0000 000.00 Completed Startup
3. Early Stage VC (Series B) 01-Mar-2013 000 00.00 0000 Completed Startup
2. Early Stage VC (Series A) 01-Sep-2011 $2.3M $2.3M 000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Thync’s complete valuation and funding history, request access »

Thync Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B2 0,000,000 00.000000 00 00.00 00.00 00.00 00.00
Series B1 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 1,328,125 $0.000100 8% $1.6 $1.6 1x $1.6 9.44%
Series A 2,875,000 $0.000100 8% $0.8 $0.8 1x $0.8 20.44%
To view Thync’s complete cap table history, request access »

Thync Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of bioelectronic products designed to offer treatments for autoimmune disorders and mental health. The company
Therapeutic Devices
Los Gatos, CA
25 As of 2017
00000000000 000.00


ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
00000000000 (000)
London, United Kingdom
0 As of 0000
000000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Thync Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000.00 Accelerator/Incubator Backed London, United Kingdom 0 0000 000000000000 0000
To view Thync’s complete competitors history, request access »

Thync Executive Team (8)

Name Title Board Seat Contact Info
Isy Goldwasser Co-Founder & Chief Executive Officer
Anil Thakur Co-Founder & Chief Technology Officer
Doug Jeffery Vice President, Consumer Product Operations & Director, Consumables & Business Development
Sean Morgan Co-Founder
Jwala Karnik MD Senior Vice President, Clinical Development
You’re viewing 5 of 8 executive team members. Get the full list »

Thync Board Members (3)

Name Representing Role Since
Max Polyakov Ph.D Self Board Member 000 0000
Samir Kaul Khosla Ventures Board Member 000 0000
To view Thync’s complete board members history, request access »

Thync Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Thync Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Andreessen Horowitz Venture Capital Minority 000 0000 000000 0
Khosla Ventures Venture Capital Minority 000 0000 000000 0
VGC Partners Growth/Expansion Minority 000 0000 000000 0
Flex's Lab IX Accelerator/Incubator 000 0000 000000 0
Plug and Play Tech Center Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »